Instil Bio, Inc. (TIL) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $842.96M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-587.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $841.92M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-532.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $840.94M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-583.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $839.33M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-612.00K.
Instil Bio, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $0.00 | $842.96M | $-587.00K | $-734.99M | $107.38M | 3 month · $1.04M | (m) |
| 2026-03-31 | $0.00 | $0.00 | $841.92M | $-532.00K | $-730.69M | $110.70M | 3 month · $985.00K | (m) |
| 2025-12-31 | $0.00 | $0.00 | $840.94M | $-583.00K | $-726.49M | $113.87M | 12 month · $8.69M | (m) |
| 2025-09-30 | $0.00 | $0.00 | $839.33M | $-612.00K | $-718.30M | $120.42M | 3 month · $1.77M | (m) |
| 2025-06-30 | $0.00 | $0.00 | $837.18M | $-805.00K | $-704.71M | $131.67M | 3 month · $1.82M | (m) |
| 2025-03-31 | $0.00 | $0.00 | $828.68M | $-451.00K | $-683.32M | $144.91M | 3 month · $3.50M | (m) |
| 2024-12-31 | $0.00 | $0.00 | $824.78M | $-228.00K | $-655.12M | $169.44M | 12 month · $17.26M | (m) |
| 2024-09-30 | $0.00 | $0.00 | $820.07M | $-520.00K | $-643.22M | $176.33M | 3 month · $4.07M | (m) |
| 2024-06-30 | $0.00 | $0.00 | $815.85M | $-627.00K | $-620.20M | $195.02M | 3 month · $4.17M | (m) |
| 2024-03-31 | $0.00 | $0.00 | $811.67M | $-563.00K | $-605.28M | $205.83M | 3 month · $4.51M | (m) |
| 2023-12-31 | $0.00 | $0.00 | $807.16M | $-348.00K | $-580.98M | $225.83M | 12 month · $18.17M | (m) |
| 2023-09-30 | $0.00 | $0.00 | $802.61M | $-525.00K | $-568.06M | $234.02M | 3 month · $4.67M | (m) |
| 2023-06-30 | $0.00 | $0.00 | $797.93M | $-795.00K | $-500.62M | $296.52M | 3 month · $4.41M | (m) |
| 2023-03-31 | $0.00 | $0.00 | $793.52M | $-406.00K | $-481.96M | $311.15M | 3 month · $4.53M | (m) |
| 2022-12-31 | $0.00 | $0.00 | $788.99M | $-493.00K | $-424.89M | $363.61M | 12 month · $30.44M | (m) |
| 2022-09-30 | (m) | $0.00 | $781.97M | $-335.00K | $-371.05M | $410.59M | 3 month · $7.99M | (m) |
| 2022-06-30 | (m) | $0.00 | $773.72M | $-557.00K | $-314.83M | $458.33M | 3 month · $8.32M | (m) |
| 2022-03-31 | (m) | $0.00 | $764.83M | $-441.00K | $-255.83M | $508.56M | 3 month · $7.49M | (m) |
| 2021-12-31 | $0.00 | $0.00 | $757.00M | $-87.00K | $-201.72M | $555.20M | 12 month · $26.20M | (m) |
| 2021-09-30 | (m) | $0.00 | $747.89M | $-104.00K | $-146.37M | $601.42M | 3 month · $8.73M | (m) |
| 2021-06-30 | (m) | $0.00 | $739.04M | $-210.00K | $-103.36M | $635.47M | 3 month · $5.75M | 3 month · $158.00K |
| 2021-03-31 | (m) | $0.00 | $733.46M | $-253.00K | $-68.05M | $665.15M | 3 month · $2.81M | (m) |
| 2020-12-31 | (m) | $0.00 | $5.61M | $-283.00K | $-44.92M | $-39.60M | 12 month · $1.71M | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | $-22.82M | 3 month · $331.00K | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | $-16.00M | 3 month · $899.00K | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | $-7.71M | 3 month · $62.00K | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | $-6.89M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |